Journal
EXPERIMENTAL BIOLOGY AND MEDICINE
Volume 235, Issue 12, Pages 1398-1411Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1258/ebm.2010.010137
Keywords
anemia; blood; erythropoiesis; erythropoietin; hypoxia; kidney
Categories
Ask authors/readers for more resources
This is a Minireview covering landmarks or milestones in the development of erythropoietin (EPO). Thirty-nine landmark advances have been identified, which cover the period 1863-2003. Several reports are included that directly support these original landmark advances. This Minireview also updates some of the advances in EPO research since my last Minireview update on EPO published in this journal in 2003. The areas of EPO research updated are: sites of production; purification, assay and standardization; regulation; action; use in anemias; extraerythropoietic actions; adverse effects; and blood doping. The new reports on the use of EPO in the therapy of myocardial infarction; stroke and other neurological diseases; diabetic retinopathy and other retinal diseases are also covered.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available